{
 "name": "得生製藥",
 "slug": "tw-7860",
 "aliases": [
  "得生製藥股份有限公司",
  "TEH SENG",
  "7860"
 ],
 "ticker": "7860",
 "industry": "生技醫療業",
 "website": "http://www.tehseng.com/",
 "summary": "得生製藥（7860）是興櫃的生技醫療類股公司，1987 年成立，2025 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "得生製藥股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "TEH SENG",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2025-09-09",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "1987-11-18",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "許海上",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "許海上",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 320000000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.tehseng.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：Flurbiprofen（富帝芬水性貼布）",
   "value": "痠痛｜已上市、台灣健保給付｜台灣",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第9頁；衛署藥製字第040358號；品牌及成分均由該頁列示。"
  },
  {
   "claim": "管線：得生活血風濕膏",
   "value": "痠痛｜中藥水性貼布已上市、列入中國醫保目錄｜中國",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第10頁；公司稱Rx/OTC雙跨。"
  },
  {
   "claim": "管線：Fentanyl（芬坦尼經皮吸收貼片）",
   "value": "癌症止痛｜已取得4劑量藥證並受委託生產｜台灣",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第12頁；12.5、25、50、75 mcg/hr，許可證050018、061539、061540、061910，實際對應見原表。"
  },
  {
   "claim": "管線：TS1802（Rivastigmine／利斯狄明貼片）",
   "value": "阿茲海默症／帕金森病相關失智｜TFDA核准、已取得基質型經皮貼片藥證｜台灣",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第8、14、26頁；原開發表產品名稱「憶思能」為參考製劑，不當成得生品牌；060824、060867。"
  },
  {
   "claim": "管線：PS142（Lidocaine 5%）",
   "value": "帶狀皰疹後神經疼痛｜已取得藥證｜新加坡、沙烏地阿拉伯、智利",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第25頁已取得與預計取證分開列，不把2026-2028預估當核准。"
  },
  {
   "claim": "催化劑：PS142（Lidocaine 5%）",
   "value": "泰國及馬來西亞取證（公司預估）｜2026（公司預估）｜已公告",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第25頁公司對外簡報的預計取證年份；尚未查得結果，保留為舊公司預估。"
  },
  {
   "claim": "催化劑：PS142（Lidocaine 5%）",
   "value": "中國大陸、科威特及瓜地馬拉取證（公司預估）｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第25頁預計取證年份；沒有補造月份或日期。"
  },
  {
   "claim": "管線：TS1810（Nicotine／尼古丁貼片）",
   "value": "尼古丁替代療法｜生物等效性試驗通過、TFDA準備申請中｜台灣",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁；表列「克戒貼片」為參考產品名稱，未當成得生商標。"
  },
  {
   "claim": "管線：TS1801（Tulobuterol）",
   "value": "支氣管哮喘／急慢性支氣管炎／肺氣腫｜已完成體外釋放／體外皮膚滲透及6個月加速試驗；BE及TFDA狀態未揭露｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁對應IVRT／IVPT／6個月加速欄為勾選，BE／TFDA空白；表列商品名為參考製劑，不當作得生商標。"
  },
  {
   "claim": "管線：TS1803（Rotigotine）",
   "value": "帕金森病｜已完成體外釋放／體外皮膚滲透及6個月加速試驗；BE及TFDA狀態未揭露｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁對應IVRT／IVPT／6個月加速欄為勾選，BE／TFDA空白；表列商品名為參考製劑，不當作得生商標。"
  },
  {
   "claim": "管線：TS1804（Scopolamine）",
   "value": "噁心與嘔吐｜已完成體外釋放／體外皮膚滲透及6個月加速試驗；BE及TFDA狀態未揭露｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁對應IVRT／IVPT／6個月加速欄為勾選，BE／TFDA空白；表列商品名為參考製劑，不當作得生商標。"
  },
  {
   "claim": "管線：TS1805（Selegiline）",
   "value": "重度憂鬱症｜已完成體外釋放／體外皮膚滲透及6個月加速試驗；BE及TFDA狀態未揭露｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁對應IVRT／IVPT／6個月加速欄為勾選，BE／TFDA空白；表列商品名為參考製劑，不當作得生商標。"
  },
  {
   "claim": "管線：TS1806（Granisetron）",
   "value": "化療引起之噁心與嘔吐｜已完成體外釋放／體外皮膚滲透及6個月加速試驗；BE及TFDA狀態未揭露｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁對應IVRT／IVPT／6個月加速欄為勾選，BE／TFDA空白；表列商品名為參考製劑，不當作得生商標。"
  },
  {
   "claim": "管線：TS1808（Oxybutynin）",
   "value": "膀胱過動症｜已完成體外釋放／體外皮膚滲透及6個月加速試驗；BE及TFDA狀態未揭露｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁對應IVRT／IVPT／6個月加速欄為勾選，BE／TFDA空白；表列商品名為參考製劑，不當作得生商標。"
  },
  {
   "claim": "管線：TS1809（Clonidine）",
   "value": "高血壓｜已完成體外釋放／體外皮膚滲透及6個月加速試驗；BE及TFDA狀態未揭露｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁對應IVRT／IVPT／6個月加速欄為勾選，BE／TFDA空白；表列商品名為參考製劑，不當作得生商標。"
  },
  {
   "claim": "管線：TS1807（Diclofenac epolamine）",
   "value": "輕微扭傷／拉傷｜體外釋放、體外皮膚滲透與6個月加速試驗進行中｜未揭露",
   "unit": "",
   "as_of": "2025-09-03",
   "source": "https://mopsov.twse.com.tw/nas/STR/786020250903M001.pdf",
   "note": "第26頁IVRT、IVPT及6個月加速三欄皆列進行中，BE及TFDA狀態空白。參考製劑Flector不是得生品牌。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-7860.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}